Feng Jian Q, Ye Ling, Schiavi Susan
Department of Biomedical Sciences, Texas A&M Health Science Center, Baylor College of Dentistry, Dallas, Texas 75246, USA.
Curr Opin Nephrol Hypertens. 2009 Jul;18(4):285-91. doi: 10.1097/MNH.0b013e32832c224f.
Osteocytes, the terminally differentiated cell of the osteoblast lineage, account for over 90% of all bone cells. Due to their relative inaccessibility within mineralized matrix, little is known regarding their specific functions in comparison to the well studied surface bone cells, osteoblasts and osteoclasts. Furthermore, bone is often viewed as a mineral reservoir that passively releases calcium and phosphate in response to hormones secreted from remote organs. Noncollagenous matrix proteins produced in osteocytes, such as dentin matrix protein 1 (DMP1), have also been viewed as inert scaffolds for calcium-phosphate deposition. Recent discoveries of new genetic mutations in human diseases and development of genetically engineered animal models challenge these classic paradigms, suggesting that the osteocyte plays an active role in both mineralization and total systemic phosphate regulation. In this review, we will focus on roles of osteocytes in mineralization and particularly in phosphate regulation via the DMP1- FGF23 pathway.
骨细胞是成骨细胞谱系的终末分化细胞,占所有骨细胞的90%以上。由于它们在矿化基质中相对难以获取,与研究充分的表面骨细胞(成骨细胞和破骨细胞)相比,人们对其特定功能知之甚少。此外,骨骼通常被视为一个矿物质储存库,它会根据远端器官分泌的激素被动释放钙和磷酸盐。骨细胞产生的非胶原蛋白基质蛋白,如牙本质基质蛋白1(DMP1),也被视为钙磷沉积的惰性支架。人类疾病中新基因突变的最新发现以及基因工程动物模型的发展挑战了这些经典范式,表明骨细胞在矿化和全身磷酸盐调节中都发挥着积极作用。在这篇综述中,我们将重点关注骨细胞在矿化中的作用,特别是通过DMP1 - FGF23途径在磷酸盐调节中的作用。